CKDXF

What one share of Opthea Limited holds

Biological Products, (No Diagnostic Substances)

Opthea Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-06-30; the balance sheet is as of 2025-06-30.

Per-share figures
Sales$0.00
Profit−$1.06
Capex (buildings and equipment)$0.00
Free cash flow−$1.04
Cash and investments$0.32
Book value−$1.31

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2022$0.00−$2.11$0.00−$1.62—$1.09
2023$0.00−$2.58$0.00−$2.18—−$0.11
2024$0.00−$2.76$0.00−$2.02—−$0.95
2025$0.00−$1.06$0.00−$1.04—−$1.31

Common questions about Opthea Limited

How much does one share of Opthea Limited earn?

Over its latest fiscal year, Opthea Limited lost $1.06 for each share on $0.00 of sales.

Does Opthea Limited pay a dividend?

Opthea Limited didn’t pay a dividend over its latest fiscal year, according to its SEC filings.

What is Opthea Limited’s book value per share?

Opthea Limited’s book value is negative (−$1.31 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2025.

How much cash and debt does each share of Opthea Limited have?

Each share of Opthea Limited has $0.32 of cash and investments, as of June 30, 2025.

What is Opthea Limited’s free cash flow per share?

−$1.04 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

Has Opthea Limited bought back shares?

Opthea Limited’s share count rose about 248% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.